Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Clinical trial NCT05691465 · RECRUITING

Trial details

NCT number: NCT05691465
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation Metastatic Prostate Neuroendocrine Carcinoma Metastatic Prostate Small Cell Neuroendocrine Carcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2023-12-27
Primary completion: 2026-11-02
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.